Cost-effectiveness of introducing licensed GP practices to manage diabetes patients in Hungary

László Szilberhorn, László Kőrösi, Péter Vajer, Balázs Nagy, Z. Vokó

Research output: Contribution to journalArticle

Abstract

Aim: To investigate the cost-effectiveness of the endowment of the same authority and responsibility in diabetes management to licensed GPs as licensed outpatient specialists in Hungary. Methods: The Syreon Diabetes Control Model (SDM) was used to evaluate life expectancy, quality-adjusted life expectancy (QALY) and direct medical costs over patient lifetimes. Cohort characteristics were derived from national database, clinical history data of 476,211 persons with diabetes were used, treatment effects and costs were derived from literature, national databases and expert opinions. Results: The purchase of one additional quality adjusted life year with the use of licensed general practitioners was EUR 51,420 compared to making the service available only through universal GPs. The purchase of one additional quality adjusted life year through the service of licensed GPs is EUR 459,950 compared to outpatient care provision. Conclusions: The management of diabetes care with licensed GPs has the potential to improve patients health gains compared to the current patterns of care in Hungary in a cost-effective way if licensed GPs are reimbursed below the average current cost of outpatient diabetes services. Increase of the capitation for diabetic patients would be a practical way to reimburse the GP's additional service.

Original languageEnglish
JournalPrimary Care Diabetes
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Hungary
Cost-Benefit Analysis
Quality-Adjusted Life Years
Ambulatory Care
Life Expectancy
Costs and Cost Analysis
Quality of Life
Databases
Expert Testimony
Financial Management
Health Care Costs
General Practitioners
Outpatients
Health

Keywords

  • Capitation payment
  • Cost effectiveness
  • Disease management
  • Licensed general practitioner
  • Modeling
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Cost-effectiveness of introducing licensed GP practices to manage diabetes patients in Hungary. / Szilberhorn, László; Kőrösi, László; Vajer, Péter; Nagy, Balázs; Vokó, Z.

In: Primary Care Diabetes, 01.01.2019.

Research output: Contribution to journalArticle

Szilberhorn, László ; Kőrösi, László ; Vajer, Péter ; Nagy, Balázs ; Vokó, Z. / Cost-effectiveness of introducing licensed GP practices to manage diabetes patients in Hungary. In: Primary Care Diabetes. 2019.
@article{d19b8a5dba944bb89fd7ca357b8168a3,
title = "Cost-effectiveness of introducing licensed GP practices to manage diabetes patients in Hungary",
abstract = "Aim: To investigate the cost-effectiveness of the endowment of the same authority and responsibility in diabetes management to licensed GPs as licensed outpatient specialists in Hungary. Methods: The Syreon Diabetes Control Model (SDM) was used to evaluate life expectancy, quality-adjusted life expectancy (QALY) and direct medical costs over patient lifetimes. Cohort characteristics were derived from national database, clinical history data of 476,211 persons with diabetes were used, treatment effects and costs were derived from literature, national databases and expert opinions. Results: The purchase of one additional quality adjusted life year with the use of licensed general practitioners was EUR 51,420 compared to making the service available only through universal GPs. The purchase of one additional quality adjusted life year through the service of licensed GPs is EUR 459,950 compared to outpatient care provision. Conclusions: The management of diabetes care with licensed GPs has the potential to improve patients health gains compared to the current patterns of care in Hungary in a cost-effective way if licensed GPs are reimbursed below the average current cost of outpatient diabetes services. Increase of the capitation for diabetic patients would be a practical way to reimburse the GP's additional service.",
keywords = "Capitation payment, Cost effectiveness, Disease management, Licensed general practitioner, Modeling, Type 2 diabetes",
author = "L{\'a}szl{\'o} Szilberhorn and L{\'a}szl{\'o} Kőr{\"o}si and P{\'e}ter Vajer and Bal{\'a}zs Nagy and Z. Vok{\'o}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.pcd.2019.03.004",
language = "English",
journal = "Primary Care Diabetes",
issn = "1751-9918",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Cost-effectiveness of introducing licensed GP practices to manage diabetes patients in Hungary

AU - Szilberhorn, László

AU - Kőrösi, László

AU - Vajer, Péter

AU - Nagy, Balázs

AU - Vokó, Z.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Aim: To investigate the cost-effectiveness of the endowment of the same authority and responsibility in diabetes management to licensed GPs as licensed outpatient specialists in Hungary. Methods: The Syreon Diabetes Control Model (SDM) was used to evaluate life expectancy, quality-adjusted life expectancy (QALY) and direct medical costs over patient lifetimes. Cohort characteristics were derived from national database, clinical history data of 476,211 persons with diabetes were used, treatment effects and costs were derived from literature, national databases and expert opinions. Results: The purchase of one additional quality adjusted life year with the use of licensed general practitioners was EUR 51,420 compared to making the service available only through universal GPs. The purchase of one additional quality adjusted life year through the service of licensed GPs is EUR 459,950 compared to outpatient care provision. Conclusions: The management of diabetes care with licensed GPs has the potential to improve patients health gains compared to the current patterns of care in Hungary in a cost-effective way if licensed GPs are reimbursed below the average current cost of outpatient diabetes services. Increase of the capitation for diabetic patients would be a practical way to reimburse the GP's additional service.

AB - Aim: To investigate the cost-effectiveness of the endowment of the same authority and responsibility in diabetes management to licensed GPs as licensed outpatient specialists in Hungary. Methods: The Syreon Diabetes Control Model (SDM) was used to evaluate life expectancy, quality-adjusted life expectancy (QALY) and direct medical costs over patient lifetimes. Cohort characteristics were derived from national database, clinical history data of 476,211 persons with diabetes were used, treatment effects and costs were derived from literature, national databases and expert opinions. Results: The purchase of one additional quality adjusted life year with the use of licensed general practitioners was EUR 51,420 compared to making the service available only through universal GPs. The purchase of one additional quality adjusted life year through the service of licensed GPs is EUR 459,950 compared to outpatient care provision. Conclusions: The management of diabetes care with licensed GPs has the potential to improve patients health gains compared to the current patterns of care in Hungary in a cost-effective way if licensed GPs are reimbursed below the average current cost of outpatient diabetes services. Increase of the capitation for diabetic patients would be a practical way to reimburse the GP's additional service.

KW - Capitation payment

KW - Cost effectiveness

KW - Disease management

KW - Licensed general practitioner

KW - Modeling

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85063357287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063357287&partnerID=8YFLogxK

U2 - 10.1016/j.pcd.2019.03.004

DO - 10.1016/j.pcd.2019.03.004

M3 - Article

JO - Primary Care Diabetes

JF - Primary Care Diabetes

SN - 1751-9918

ER -